Neuroprotective Effect of Dimethyl Fumarate in Stroke: The Role of Nuclear Factor Erythroid 2-related Factor 2

Overview

Journal Iran J Neurol

Publisher Tehran University of Medical Sciences

Date 2019 Nov 22

PMID 31749931

Citations 10

Authors

Anahid Safari

Hamzeh Badeli-Sarkala

Mohammad Reza Namavar

Elias Kargar-Abarghouei

Neda Anssari

Sadegh Izadi

Afshin Borhani-Haghighi

Affiliations

Soon will be listed here.

Abstract

There is evidence that supports the neuroprotective effects of dimethyl fumarate (DMF) in stroke. Nuclear factor erythroid 2-related factor 2 (Nrf2) has both anti-oxidant and anti-inflammatory mechanisms. We investigated the neuroprotective effects of DMF via Nrf2 activation in the cortex, striatum, and diencephalon in a middle cerebral artery occlusion (MCAO) model of stroke. 22 Sprague-Dawley male rats were randomized into 3 groups. In DMF-treated group (n = 8), rats received 15 mg/kg oral DMF twice daily by gavage from day 0 to 14 after a 60-minute MCAO. The vehicle group (n = 7) underwent MCAO and were given methocel/HO, using the same method and schedule. In the sham group (n = 7), neck was opened, but neither middle cerebral artery (MCA) was occluded nor any drug was administered. After 14 days, the animals were sacrificed. The infarct volume were assessed by stereology method. Nrf2 expression was evaluated in the cortex, striatum, and diencephalon by immunohistochemistry method. Ratio of infarct to total brain volume was significantly lower in the DMF-treated group (5.76%) in comparison with the vehicle group (22.39%) (P < 0.0001). Nrf2 expression was higher in DMF-treated group in comparison with both the vehicle and sham groups in cortex, striatum, diencephalon, and total brain (P < 0.0001). In the DMF-treated group, significant negative correlation between Nrf2 expression and infarct volume was observed in cortex, striatum, diencephalon, and total brain. DMF induces Nrf2 expression and its neuroprotective effects in different brain anatomical regions.

Citing Articles

Major Depressive Disorder and Gut Microbiota: Role of Physical Exercise.

Borges de Souza P, de Araujo Borba L, Castro de Jesus L, Valverde A, Gil-Mohapel J, Rodrigues A Int J Mol Sci. 2023; 24(23).

PMID: 38069198 PMC: 10706777. DOI: 10.3390/ijms242316870.

Dimethyl Fumarate Attenuates Lymphocyte Infiltration and Reduces Infarct Size in Experimental Stroke.

Schuhmann M, Langhauser F, Zimmermann L, Bellut M, Kleinschnitz C, Fluri F Int J Mol Sci. 2023; 24(21).

PMID: 37958527 PMC: 10648192. DOI: 10.3390/ijms242115540.

Novel potential pharmacological applications of dimethyl fumarate-an overview and update.

Bresciani G, Manai F, Davinelli S, Tucci P, Saso L, Amadio M Front Pharmacol. 2023; 14:1264842.

PMID: 37745068 PMC: 10512734. DOI: 10.3389/fphar.2023.1264842.

Emerging roles of GPR109A in regulation of neuroinflammation in neurological diseases and pain.

Taing K, Chen L, Weng H Neural Regen Res. 2022; 18(4):763-768.

PMID: 36204834 PMC: 9700108. DOI: 10.4103/1673-5374.354514.

The Role of Concomitant Nrf2 Targeting and Stem Cell Therapy in Cerebrovascular Disease.

Gordon J, Lockard G, Monsour M, Alayli A, Borlongan C Antioxidants (Basel). 2022; 11(8).

PMID: 35892653 PMC: 9332234. DOI: 10.3390/antiox11081447.

References

Clausen B, Lundberg L, Yli-Karjanmaa M, Martin N, Svensson M, Alfsen M . Fumarate decreases edema volume and improves functional outcome after experimental stroke. Exp Neurol. 2017; 295:144-154. DOI: 10.1016/j.expneurol.2017.06.011. View

Dang J, Brandenburg L, Rosen C, Fragoulis A, Kipp M, Pufe T . Nrf2 expression by neurons, astroglia, and microglia in the cerebral cortical penumbra of ischemic rats. J Mol Neurosci. 2011; 46(3):578-84. DOI: 10.1007/s12031-011-9645-9. View

Kim Y, Huang I, Lee S, Tejima E, Mandeville J, van Meer M . Measurements of BOLD/CBV ratio show altered fMRI hemodynamics during stroke recovery in rats. J Cereb Blood Flow Metab. 2005; 25(7):820-9. DOI: 10.1038/sj.jcbfm.9600084. View

Allen C, Bayraktutan U . Oxidative stress and its role in the pathogenesis of ischaemic stroke. Int J Stroke. 2009; 4(6):461-70. DOI: 10.1111/j.1747-4949.2009.00387.x. View

Zhang R, Xu M, Wang Y, Xie F, Zhang G, Qin X . Nrf2-a Promising Therapeutic Target for Defensing Against Oxidative Stress in Stroke. Mol Neurobiol. 2016; 54(8):6006-6017. DOI: 10.1007/s12035-016-0111-0. View

Yao Y, Miao W, Liu Z, Han W, Shi K, Shen Y . Dimethyl Fumarate and Monomethyl Fumarate Promote Post-Ischemic Recovery in Mice. Transl Stroke Res. 2016; 7(6):535-547. PMC: 5065588. DOI: 10.1007/s12975-016-0496-0. View

Copple I, Dinkova-Kostova A, Kensler T, Liby K, Wigley W . NRF2 as an Emerging Therapeutic Target. Oxid Med Cell Longev. 2017; 2017:8165458. PMC: 5306997. DOI: 10.1155/2017/8165458. View

Alfieri A, Srivastava S, Siow R, Modo M, Fraser P, Mann G . Targeting the Nrf2-Keap1 antioxidant defence pathway for neurovascular protection in stroke. J Physiol. 2011; 589(17):4125-36. PMC: 3180573. DOI: 10.1113/jphysiol.2011.210294. View

Borhani-Haghighi A, Safari R, Heydari S, Soleimani F, Sharifian M, Yektaparast Kashkuli S . Hospital mortality associated with stroke in southern iran. Iran J Med Sci. 2013; 38(4):314-20. PMC: 3838983. View

10.

Shahtaheri R, Haghighi A, Safari A, Cruz-Flores S . Recombinant tissue plasminogen activator (rtPA) and stroke unit for acute ischaemic stroke in developing countries, are they cost-effective?. Int J Stroke. 2012; 7(7):E9. DOI: 10.1111/j.1747-4949.2012.00892.x. View

11.

Mrowietz U, Asadullah K . Dimethylfumarate for psoriasis: more than a dietary curiosity. Trends Mol Med. 2005; 11(1):43-8. DOI: 10.1016/j.molmed.2004.11.003. View

12.

Veselkina O, Morozov V, Korzhevskii D, Tihonov D, Barygin O, Isaeva A . Neuroprotective activity of creatylglycine ethyl ester fumarate. J Stroke Cerebrovasc Dis. 2015; 24(3):591-600. DOI: 10.1016/j.jstrokecerebrovasdis.2014.10.005. View

13.

Rojo de la Vega M, Krajisnik A, Zhang D, Wondrak G . Targeting NRF2 for Improved Skin Barrier Function and Photoprotection: Focus on the Achiote-Derived Apocarotenoid Bixin. Nutrients. 2017; 9(12). PMC: 5748821. DOI: 10.3390/nu9121371. View

14.

Ansari S, Azari H, McConnell D, Afzal A, Mocco J . Intraluminal middle cerebral artery occlusion (MCAO) model for ischemic stroke with laser doppler flowmetry guidance in mice. J Vis Exp. 2011; (51). PMC: 3197429. DOI: 10.3791/2879. View

15.

Gold R, Linker R, Stangel M . Fumaric acid and its esters: an emerging treatment for multiple sclerosis with antioxidative mechanism of action. Clin Immunol. 2011; 142(1):44-8. DOI: 10.1016/j.clim.2011.02.017. View

16.

Bray M, Vokes M, Carpenter A . Using CellProfiler for Automatic Identification and Measurement of Biological Objects in Images. Curr Protoc Mol Biol. 2015; 109:14.17.1-14.17.13. PMC: 4302752. DOI: 10.1002/0471142727.mb1417s109. View

17.

Rodrigo R, Fernandez-Gajardo R, Gutierrez R, Matamala J, Carrasco R, Miranda-Merchak A . Oxidative stress and pathophysiology of ischemic stroke: novel therapeutic opportunities. CNS Neurol Disord Drug Targets. 2013; 12(5):698-714. DOI: 10.2174/1871527311312050015. View

18.

Safari A, Fazeli M, Namavar M, Tanideh N, Jafari P, Borhani-Haghighi A . Therapeutic effects of oral dimethyl fumarate on stroke induced by middle cerebral artery occlusion: An animal experimental study. Restor Neurol Neurosci. 2017; 35(3):265-274. DOI: 10.3233/RNN-160670. View

19.

Moharregh-Khiabani D, Blank A, Skripuletz T, Miller E, Kotsiari A, Gudi V . Effects of fumaric acids on cuprizone induced central nervous system de- and remyelination in the mouse. PLoS One. 2010; 5(7):e11769. PMC: 2909255. DOI: 10.1371/journal.pone.0011769. View

20.

Belge K, Bruck J, Ghoreschi K . Advances in treating psoriasis. F1000Prime Rep. 2014; 6:4. PMC: 3883421. DOI: 10.12703/P6-4. View